Drug release testing methods of polymeric particulate drug formulations
Tóm tắt
The long-term controlled delivery of drugs has been successfully achieved by biodegradable polymeric particulate systems. The drug release testing method is important for the characterization of dosage form performance under in vitro standardized conditions and can provide insight into the in vivo performance of the drug product. In vitro drug release testing methods for polymeric particulate systems are classified into sample and separate (SS), dialysis, and continuous flow (CF) methods. In the SS method, the drug-loaded microparticles are suspended in a vessel and the samples for the analysis are obtained by separating the particles using filtration or centrifugation. The dialysis method physically separates microparticles from the release media by a membrane, which eliminates the undesired loss of particles during sample preparation and handling. The CF method uses apparatus consisted of flow-through cell that holds the sample, pump and water bath in closed or open ends system. In this method, the release media is continuously circulated through a cell containing drug-loaded microparticles. This review summarizes the principles of the drug release testing methods and discusses their characteristics with the recent research results.
Tài liệu tham khảo
Ahmed TA, Ibrahim HM, Ibrahim F, Samy AM, Kaseem A, Nutan MT, Hussain MD (2012) Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol. J Pharm Sci 101:3753–3762
Anderson JM, Shive MS (1997) Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 28:5–24
Asadishad B, Vossoughi M, Alamzadeh I (2010) In vitro release behavior and cytotoxicity of doxorubicin-loaded gold nanoparticles in cancerous cells. Biotechnol Lett 32:649–654
Aubert-Pouëssel A, Venier-Julienne MC, Clavreul A, Sergent M, Jollivet C, Montero-Menei CN, Garcion E, Bibby DC, Menei P, Benoit JP (2004) In vitro study of GDNF release from biodegradable PLGA microspheres. J Control Release 95:463–475
Bodmeier R, McGinity JW (1987) The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method. Pharm Res 4:465–471
Brown CK, Friedel HD, Barker AR, Buhse LF, Keitel S, Cecil TL, Kraemer J, Morris JM, Reppas C, Stickelmeyer MP, Yomota C, Shah VP (2011) FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech 12:782–794
Choi JS, Seo K, Yoo JW (2012) Recent advances in PLGA particulate systems for drug delivery. J Pharm Invest 42:155–163
Cleland JL (1995) Design and production of single immunization vaccines using polylactide polyglycolide microsphere systems. In: Powell MF, Newman MJ (eds) Vaccine Design. Plenum, New York, pp 439–472
Conti B, Genta I, Giunchedi P, Modena T (1995) Testing of “in vitro” dissolution behavior of microparticulate drug delivery systems. Drug Dev Ind Pharm 21:1223–1233
D’Souza SS, DeLuca PP (2005) Development of a dialysis in vitro release method for biodegradable microspheres. AAPS PharmSciTech 6:E323–E328
D’Souza SS, DeLuca PP (2006) Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharm Res 23:460–474
D’Souza SS, Faraj JA, DeLuca PP (2005) A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres. AAPS PharmSciTech 6:E553–E564
Gombotz WR, Pettit DK (1995) Biodegradable polymers for protein and peptide drug delivery. Bioconjug Chem 6:332–351
Guerrero S, Muñíz E, Teijón C, Olmo R, Teijón JM, Blanco MD (2008) Ketotifen-loaded microspheres prepared by spray-drying poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) polymers: characterization and in vivo evaluation. J Pharm Sci 97:3153–3169
Jeong YI, Song JG, Kang SS, Ryu HH, Lee YH, Choi C, Shin BA, Kim KK, Ahn KY, Jung S (2003) Preparation of poly(dl-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid. Int J Pharm 259:79–91
Kim H, Burgess DJ (2002) Effect of drug stability on the analysis of release data from controlled release microspheres. J Microencapsul 19:631–640
Kinget R, Bontinck AM, Herbots H (1979) Problems of dialysis techniques in the study of macromolecule binding of drugs. Int J Pharm 3:65–72
Klose D, Siepmann F, Elkharraz K, Siepmann J (2008) PLGA-based drug delivery systems: importance of the type of drug and device geometry. Int J Pharm 354:95–103
Larsen DB, Joergensen S, Olsen NV, Hansen SH, Larsen C (2002) In vivo release of bupivacaine from subcutaneously administered oily solution. Comparison with in vitro release. J Control Release 81:145–154
Larsen C, Larsen SW, Jensen H, Yaghmur A, Ostergaard J (2009) Role of in vitro release models in formulation development and quality control of parenteral depots. Expert Opin Drug Deliv 6:1283–1295
Liggins RT, Burt HM (2001) Paclitaxel loaded poly(l-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers. Int J Pharm 222:19–33
Maestrelli F, Mura P, Alonso MJ (2004) Formulation and characterization of triclosan sub-micron emulsions and nanocapsules. J Microencapsul 21:857–864
Mitra A, Wu Y (2010) Use of in vitro–in vivo correlation (IVIVC) to facilitate the development of polymer-based controlled release injectable formulation. Recent Pat Drug Deliv Formul 4:94–104
Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM (2008) Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J Control Release 125:193–209
Murty SB, Goodman J, Thanoo BC, DeLuca PP (2003) Identification of chemically modified peptide from poly(d,l-lactide-co-glycolide) microspheres under in vitro release conditions. AAPS PharmSciTech 4:E50
Murty SB, Na DH, Thanoo BC, DeLuca PP (2005) Impurity formation studies with peptide-loaded polymeric microspheres Part II. In vitro evaluation. Int J Pharm 297:62–72
Park EJ, Na DH, Lee KC (2007) In vitro release study of mono-PEGylated growth hormone-releasing peptide-6 from PLGA microspheres. Int J Pharm 343:281–283
Park JH, Ye M, Park K (2005) Biodegradable polymers for microencapsulation of drugs. Molecules 10:146–161
Park EJ, Amatya S, Kim MS, Park JH, Seol E, Lee H, Shin YH, Na DH (2013) Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia. Arch Pharm Res. doi:10.1007/s12272-013-0105-7
Parshad H, Frydenvang K, Liljefors T, Cornett C, Larsen C (2003) Assessment of drug salt release from solutions, suspensions and in situ suspensions using a rotating dialysis cell. Eur J Pharm Sci 19:263–272
Rawat A, Burgess DJ (2011) USP apparatus 4 method for in vitro release testing of protein loaded microspheres. Int J Pharm 409:178–184
Rawat A, Stippler E, Shah VP, Burgess DJ (2011) Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal Consta. Int J Pharm 420:198–205
Rawat A, Bhardwaj U, Burgess DJ (2012) Comparison of in vitro–in vivo release of Risperdal Consta microspheres. Int J Pharm 434:115–121
Schoubben A, Blasi P, Deluca PP (2012) Effect of agitation regimen on the in vitro release of leuprolide from poly(lactic-co-glycolic) acid microparticles. J Pharm Sci 101:1212–1220
Schultz K, Møllgaard B, Frokjaer S, Larsen C (1997) Rotating dialysis cell as in vitro release method for oily parenteral depot solutions. Int J Pharm 157:163–169
Shen J, Burgess DJ (2012) Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings. Int J Pharm 422:341–348
Tunçay M, Caliş S, Kaş HS, Ercan MT, Peksoy I, Hincal AA (2000) Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation. Int J Pharm 195:179–188
Vandelli MA, Rivasi F, Guerra P, Forni F, Arletti R (2001) Gelatin microspheres crosslinked with d,l-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies. Int J Pharm 215:175–184
Voisine JM, Zolnik BS, Burgess DJ (2008) In situ fiber optic method for long-term in vitro release testing of microspheres. Int J Pharm 356:206–211
Wagenaar BW, Müller BW (1994) Piroxicam release from spray-dried biodegradable microspheres. Biomaterials 15:49–54
Wang J, Wang BM, Schwendeman SP (2002) Characterization of the initial burst release of a model peptide from poly(d,l-lactide-co-glycolide) microspheres. J Control Release 82:289–307
Wei G, Pettway GJ, McCauley LK, Ma PX (2004) The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres. Biomaterials 25:345–352
Wischke C, Schwendeman SP (2008) Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm 364:298–327
Xu Q, Hashimoto M, Dang TT, Hoare T, Kohane DS, Whitesides GM, Langer R, Anderson DG (2009) Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery. Small 5:1575–1581
Xu X, Khan MA, Burgess DJ (2012) A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes. Int J Pharm 426:211–218
Yang YY, Chia HH, Chung TS (2000) Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. J Control Release 69:81–96
Yen SY, Sung KC, Wang JJ, Yoa-Pu Hu O (2001) Controlled release of nalbuphine propionate from biodegradable microspheres: in vitro and in vivo studies. Int J Pharm 220:91–99
Zolnik BS, Burgess DJ (2008) Evaluation of in vivo–in vitro release of dexamethasone from PLGA microspheres. J Control Release 127:137–145
Zolnik BS, Leary PE, Burgess DJ (2006) Elevated temperature accelerated release testing of PLGA microspheres. J Control Release 112:293–300